GM
Genomtec S.A.
GMT.WA · WSE
3.61 zł -1.10% (-0.04 zł)
1M -4.50%
Market Cap 62.3M zł
P/E Ratio -
Div. Yield -
ROE 95.46%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.88x
P/S 1,946.43x
P/FFO N/A
Growth
22 /100
Declining Book val. growth 23.53%
Rev. growth 19.33%
FCF growth N/A
Profitability
0 /100
Weak Net margin 29,443.80%
Op. margin 45,118.80%
FCF margin 30,765.60%
Quality
0 /100
Poor ROE 95.46%
ROA 72.02%
Asset turnover 0.00x
Debt
67 /100
Low Current ratio 1.77x
Int. coverage -45.66x
Debt/Equity 0.25x
Stability
29 /100
Unstable Rev. volatility 1,183.85%
EPS volatility 27.71%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na GMT.WA
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Miron Tokarski
Employees
32
Headquarters
Wroclaw